Interventional Cardiology & Peripheral Vascular Devices Market Size by product (Interventional Catheters, Guidewires, Stents {Bioabsorbable Stents, Drug Eluting Stents, Bare Metal Stents}, PTCA Balloons, Atherectomy Devices, Chronic Total Occlusion Device

Interventional Cardiology & Peripheral Vascular Devices Market Size by product (Interventional Catheters, Guidewires, Stents {Bioabsorbable Stents, Drug Eluting Stents, Bare Metal Stents}, PTCA Balloons, Atherectomy Devices, Chronic Total Occlusion Devices, Synthetic Surgical Grafts, Embolic Protection Devices, Inferior Vena Cava Filters), By Application (Congenital Heart Defect Correction, Coronary Thrombectomy, Angioplasty, Valvuloplasty, Percutaneous Valve Repair), By End-use (Hospitals, Ambulatory Surgical Centers), Industry Analysis Report, Regional Outlook, Application Potential, Price Trends, Competitive Market Share & Forecast, 2020 - 2026

The interventional cardiology and peripheral vascular devices market is anticipated to witness tremendous gains in the coming years due to rising geriatric population, increasing innovations and adoption of stents across emerging economies, surging need for treatment of blood clots to prevent life-threatening health conditions, and growing number of cath labs as well as cardiac centers.

Interventional cardiology is basically a specialty area within the larger field of cardiology. It deals mostly with catheter- based treatment of heart diseases. With rising geriatric population, the burden of PAD (peripheral artery disease) is increasing. The treatment for this is usually performed by interventional cardiologists, interventional radiologists, and vascular surgeons.

Interventional cardiology and peripheral vascular devices market are divided into various segments in terms of product, application, end-use, and regional landscape.

Based on product, the market for interventional cardiology and peripheral vascular devices is classified into IVC filters, embolic protection devices, synthetic surgical grafts, chronic total occlusion devices, atherectomy devices, PTCA balloons, stents, guidewires, interventional catheters, and others. Among these, embolic protection devices segment will witness a CAGR of more than 8.2% over the forecast time period.

The primary focus of these devices is essentially on prevention and reduction of embolization during vascular interventions. Embolic protection devices are specifically designed to capture as well as remove debris that might be dislodged during interventional procedures.

In terms of application, the overall interventional cardiology and peripheral vascular devices market is bifurcated into percutaneous valve repair, valvuloplasty, angioplasty, coronary thrombectomy, congenital heart defect correction, and others. Among these, the coronary thrombectomy segment will witness tremendous growth over the coming years.

In fact, in 2019, the segment reached a valuation of approximately $1.2 billion. Growing need to treat blood clots for effective prevention of life-threatening health conditions will augment thrombectomy procedures segment growth. Mechanical thrombectomy devices are mainly used to decrease the thrombus burden in such high-risk procedures for reducing the risk of slow flow and no-reflow and distal embolization.

With respect to end-use, the overall market is categorized into ambulatory surgical centers, hospitals, and others. Among these, the others segment will grow with more than 8.6 % CAGR over the forthcoming time period. This anticipated growth is ascribed to the growing number of cardiac centers, cath labs, and ablation centers across the globe.

From a regional frame of reference, Asia-Pacific Interventional cardiology and peripheral vascular devices market will witness substantial growth owing to the growing innovations and adoption of stents among emerging economies. Other factors such as expanding geriatric patient pool in countries like China, Japan and India along with price reduction of stents will further contribute towards regional market growth.